Why scientific societies should involve more ECRs
eLifeArticle from eLife looks at the level of influence ECRs have on scientific societies, and provides guidelines on how societies can successfully include ECRs
Dissemination
Introducing the Coarse-Grained Plaque—A New Type of Amyloid
Alz ForumYou’d think that by now we would know all about what amyloid plaques look like? Well, no. Researchers just characterized what they believe to be a distinct type
Guest Blog – More research should take place in areas with most disease
Adam SmithResearch shows research participation is on the increase, however health research does not take place in areas where the burden of disease is highest
Dementia Research Chatathon Live
Dementia ResearcherOn the 7th September, Adam Smith hosted a marathon 12 hour live-stream session, talking with 56 researchers and four special guests.
CZI Awards $4.5M to Advance Innovative Approaches to Fighting Neurodegenerative Diseases
Chan Zuckerberg Initiative gives $4.5m to support researchers to collaborate and apply novel approaches for gaining greater insight into neurodegeneration
Report Highlights Barriers for Trials in Alzheimer’s
A new Gates Ventures report found that current trials are ‘more complicated, costly and slower’ when compared to other health areas.
Blog – Anti-Racism in STEM
Maya Gosztyla is working to facilitate more productive conversations (and in turn, tangible systemic changes) toward addressing racial discrimination in STEM
NIA – National Summit on Dementia Care Research PT2
Recording from the US NIA Summit Virtual Meeting Series: 2020 Care, Services, and Supports for Persons with Dementia and Their Caregivers
NIA – National Summit on Dementia Care Research PT1
Sharing the recordings from the US NIA Summit Virtual Meeting Series: 2020 Care, Services, and Supports for Persons with Dementia and their Caregivers
15/1: How many applications does it take to get a job offer
Nature Careers BlogSurvey finds that standard metrics of success can’t completely explain why some candidates get academic job offers and others don’t.
The growth of acronyms in the scientific literature
Some acronyms are useful and are widely understood, but many acronyms used in scientific papers hinder understanding, this article explores the issues.
Biogen Asks FDA To Approve Aducanumab
The first new drug for Alzheimer’s disease in more than 16 years in the U.S.? The FDA will be making a judgement within the next six months.